Fundamentals

Valuation

Metric	Q1	Q2	Δ in %
EV/EBITDA	-21.35	94.39	120.01
Graham Fair Price	57.46	51.05	32.42
PEG	-88.65	0.20	-1.80
Price/Book	-19.58	13.45	16.73
Price/Cash Flow	-55.31	105.16	235.33
Prices/Earnings	-69.57	31.74	104.29
Price/Sales	-24.63	37.61	49.91
Price/FCF	-55.31	105.16	235.33
Naive Interpretation	member

01 - Valuation · Weak

Fundamentals

Profitability

Metric	Q1	Q2	Δ in %
Gross Profit Margin	0.16	0.88	0.88
Operating Margin	-3.52	0.36	0.37
ROA	143.09	0.05	0.02
ROE	0.04	0.11	164.26
ROIC	0.06	0.07	17.41
Naive Interpretation	member

02 - Profitability · Not Interpreted

Fundamentals

Financial Growth

Metric	Q1	Q2	Δ in %
Debt QOQ	0.49	< 0.005	33250.95
Dividends QOQ	0.00	0.00	0.00
EBIT QOQ	0.09	-0.01	-87.74
EPS QOQ	-0.58	1.55	168.17
FCF QOQ	-0.29	0.73	150.18
Revenue QOQ	0.03	0.02	-7.67
Naive Interpretation	member

03 - Financial Growth · Weak

Fundamentals

Leverage & Liquidity

Metric	Q1	Q2	Δ in %
Assets Turnover	n.A.	n.A.	n.A.
Days Inventory Outstanding (DIO)	0.00	0.00	0.00
Days Sales Outstanding (DSO)	38.38	27.33	-28.80
Inventory Turnover	0.00	0.00	0.00
Debt/Capitalization	0.19	0.28	43.29
Quick Ratio	0.95	1.02	7.88
Naive Interpretation	member

04 - Leverage & Liquidity · Weak

Fundamentals

Per Share Metrics

Metric	Q1	Q2	Δ in %
Book Value	34.13	33.06	-3.14
Cash	15.06	17.96	19.31
Capex	-0.17	-0.09	44.85
Free Cash Flow	2.43	4.23	74.33
Revenue	11.44	11.82	3.36
Naive Interpretation	member

05 - Per Share Metrics · Best

Fundamentals

Financial Health

Metric	Q1	Q2	Δ in %
Current Ratio	1.05	1.16	10.87
Debt/Assets	n.A.	n.A.	n.A.
Debt/Equity	n.A.	n.A.	n.A.
Net Debt/EBITDA	-1.01	-0.75	26.27
Naive Interpretation	Member

06 - Financial Health · Bad

Rating